Nutraceutical Business Review Nutraceutical Business Review
  • Home
  • Ingredients
  • Research & Development
  • Manufacturing
  • Packaging
  • Events
  • Directory
  • Active Nutrition
  • Cardiovascular
  • Digestion
  • Cognitive
  • Finance
  • Regulatory

Pfizer

25-Jun-2019
Manufacturing | Ingredients | Research & Development | Pharmaceutical | Nutraceutical

Companies

  • Pfizer

Related Content

Pfizer and GSK joint venture creates the industry's largest OTC business
Pfizer and GSK joint venture creates the industry's largest OTC business
GSK and Pfizer deal shows shift in strategy shift to create the leader in over-the-counter products
GSK and Pfizer deal shows shift in strategy shift to create the leader in over-the-counter products
Sirio Pharma sells Treerly to Pfizer
Sirio Pharma sells Treerly to Pfizer
Chrondroitin outperforms celecoxib in knee osteoarthritis study
Chrondroitin outperforms celecoxib in knee osteoarthritis study
Chondroitin and glucosamine as effective as cox-2 inhibitors in treatment of osteoarthritis
Chondroitin and glucosamine as effective as cox-2 inhibitors in treatment of osteoarthritis
A green path to high potency
A green path to high potency
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company